ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 261726 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 261726; 2) Community: the network communities that were significantly associated with the response to NSC 261726; 3) Molecule: the relationships between components within communities and NSC 261726; 4) MDR: the compounds that were significantly associated with the NSC 261726.

NSC Compound Enrichment Correlation
NSC 734307 3,4-Dihydroxy-N(3-O-methyl-estra-1,3,5(10)-trien-ol-17b-yl)c innamide 0.0267520285931239 0.32501163
NSC 737342 6-(3-Azidopropyl)-5,6-dihydro-2,3,9-trimethoxy-5,11-dioxo-11 H-indeno[1,2-c]isoquinoline 0.0267520285931239 0.26386073
NSC 737733 1N-[4-chloro-2-(2-chlorobenzoyl)phenyl]-2-[4-(2-pheridyl)hex ahydro-1-pyrazinyl]acetamide 0.0267520285931239 0.20564951
NSC 743396 Null 0.0267520285931239 0.24303031
NSC 265211 NSC 265211 0.0268790882218881 0.18206517
NSC 287459 Cytarabine AY 0.0268790882218881 0.20378011
NSC 329127 Null 0.0268790882218881 0.32729672
NSC 35580 Null 0.0268790882218881 0.27512496
NSC 58903 Null 0.0268790882218881 0.25836923
NSC 606488 Tris(2-cyanoethyl)phosphine gold 2,3,4,6 tetra-O- acetyl-1-seleno-D-glucopyranoside 0.0268790882218881 0.20178428
Total:73  Current:42    [First] [Prev] [Next] [Last]